Rigel Pharmaceutical Inc. buy Citigroup Inc.
Start price
07.03.24
/
50%
€1.40
Target price
07.03.25
€3.67
Performance (%)
-47.24%
End price
08.03.25
-
Summary
This prediction is currently being closed. The BUY prediction by Citigroup_Inc_ for Rigel Pharmaceutical Inc. is performing very badly with a performance of -47.24%. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Rigel Pharmaceutical Inc. | - | - | - |
| iShares Core DAX® | -3.520% | -4.987% | 1.926% |
| iShares Nasdaq 100 | 0.261% | 1.102% | 15.434% |
| iShares Nikkei 225® | -4.953% | -3.352% | 29.010% |
| iShares S&P 500 | -0.823% | -0.042% | 10.814% |
Comments by Citigroup_Inc_ for this prediction
In the thread Rigel Pharmaceutical Inc. diskutieren
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) had its price target raised by analysts at Citigroup Inc. from $3.00 to $4.00. They now have a "buy" rating on the stock.
Ratings data for RIGL provided by MarketBeat
In the thread Trading Rigel Pharmaceutical Inc.
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Citigroup_Inc_ for Rigel Pharmaceutical Inc.
Rigel Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€0.74
06.03.25
06.03.25
€50.83
06.03.26
06.03.26
-
07.03.26
07.03.26
Rigel Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€0.74
12.11.24
12.11.24
€46.15
12.11.25
12.11.25
-
13.11.25
13.11.25